Description

Tucaxen 150mg by Everest Pharmaceuticals is a prescription medication containing Tucatinib, a kinase inhibitor used in the treatment of HER2-positive breast cancer. It is typically administered in combination with trastuzumab and capecitabine for patients who have received prior anti-HER2 therapies.

Key Features:

• Composition: Each tablet contains 150 mg of Tucatinib.

• Indication: Used for locally advanced unresectable or metastatic HER2-positive breast cancer.

• Dosage: Taken orally, 300 mg twice daily (about 12 hours apart), with or without food12.

• Mechanism of Action: Tucatinib blocks the activity of the tyrosine kinase enzyme, which is involved in the HER2 and HER3 pathways, thereby inhibiting the growth of cancer cells2.

Side Effects:

• Common Side Effects: Diarrhea, hand-foot syndrome, nausea, fatigue, liver problems, vomiting, mouth sores/pain, weight loss, muscle/joint pain, loss of appetite, abdominal pain, headache, anemia, and rash1.

• Serious Side Effects: May include severe liver damage or increased risk of infections.

Precautions:

• Pregnancy and Breastfeeding: Not recommended due to potential harm to the fetus or baby2.

• Driving and Machinery: Avoid driving or operating heavy machinery due to potential dizziness2.

• Interactions: May interact with other medications; consult a doctor if taking other drugs